CG Oncology Inc. (CGON) vs Hims & Hers Health, Inc. (HIMS)
A side-by-side comparison of CG Oncology Inc. and Hims & Hers Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGON
CG Oncology Inc.
$69.17HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
HIMS
Hims & Hers Health, Inc.
$29.67HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CGON vs HIMS
growth of $100 · dividends reinvested · last 3yCGON +84.9% (+22.7%/yr)HIMS +226.4% (+48.3%/yr)HIMS compounded faster over this window
CGON HIMS
CGON vs HIMS: by the numbers
- •HIMS is the larger company ($6.62B vs $6.10B market cap).
- •Both run net losses; HIMS's is the smaller (-5.51% vs -3602.68% net margin).
Metrics side by side
Valuation
| Metric | CGON | HIMS |
|---|---|---|
| P/S ratio | 979.60 | 2.57 |
| P/B ratio | 5.93 | 20.42 |
| FCF yield | N/A | 1.36% |
Profitability
| Metric | CGON | HIMS |
|---|---|---|
| Gross margin | -15.02% | 73.84% |
| Operating margin | -4722.13% | 4.50% |
| Net margin | -3602.68% | -5.51% |
| ROE | -21.80% | -43.83% |
| ROIC | -24.33% | -4.30% |
Growth (annualized)
| Metric | CGON | HIMS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 67.47% |
| Total return CAGR (5Y) | N/A | 32.23% |
Go deeper
Dig into the metrics
CG Oncology ROEHims & Hers Health ROECG Oncology operating marginHims & Hers Health operating marginCG Oncology revenue growthHims & Hers Health revenue growthCG Oncology free cash flowHims & Hers Health free cash flow
CG Oncology & Hims & Hers Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.